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Abstract
Although the higher incidence of stress-related psychiatric disorders in females is well 
documented, its basis is unknown. Here we demonstrate that the receptor for corticotropin-
releasing factor (CRF), the neuropeptide that orchestrates the stress response, signals and is 
trafficked differently in female rats in a manner that could result in a greater response and 
decreased adaptation to stressors. Most cellular responses to CRF in the brain are mediated by 
CRF receptor (CRFr) association with the GTP-binding protein, Gs. Receptor 
immunoprecipitation studies revealed enhanced CRFr-Gs coupling in cortical tissue of unstressed 
female rats. Previous stressor exposure abolished this sex difference by increasing CRFr-Gs 
coupling selectively in males. These molecular results mirrored the effects of sex and stress on 
sensitivity of locus ceruleus (LC)-norepinephrine neurons to CRF. Differences in CRFr trafficking 
were also identified that could compromise stress adaptation in females. Specifically, stress-
induced CRFr association with β-arrestin2, an integral step in receptor internalization, occurred 
only in male rats. Immunoelectron microscopy confirmed that stress elicited CRFr internalization 
in LC neurons of male rats exclusively, consistent with reported electrophysiological evidence for 
stress-induced desensitization to CRF in males. Together, these studies identified two aspects of 
CRFr function, increased cellular signaling and compromised internalization, which render CRF-
receptive neurons of females more sensitive to low levels of CRF and less adaptable to high levels 
of CRF. CRFr dysfunction in females may underlie their increased vulnerability to develop stress-
related pathology, particularly that related to increased activity of the LC-norepinephrine system, 
such as depression or post-traumatic stress disorder.
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Stress-related psychiatric disorders (e.g., depression, post-traumatic stress disorder) are 
twice as prevalent in women compared to men (1-3). Although the neurobiological basis for 
this is unknown, differences in stress reactivity have been implicated in this disparity (4-7). 
Because corticotropin-releasing factor (CRF), a primary mediator of the stress response, is 
dysregulated in stress-related psychiatric disorders, it is a likely substrate for sex differences 
in stress vulnerability (8-11). Indeed, evidence for direct estrogenic regulation of CRF gene 
expression provides a compelling mechanism for sexual dimorphism of stress reactivity and 
prevalence of stress-related psychopathology in women (12, 13).
CRF acts as a neurohormone to initiate the hypothalamic-pituitary-adrenal response to stress 
and as a neurotransmitter to initiate autonomic, behavioral, and cognitive components of the 
stress response (14-16). One target of CRF neurotransmission is the locus ceruleus (LC), the 
source of the major brain norepinephrine system that regulates emotional arousal (17-20). 
CRF activates LC neurons during stress and this is associated with heightened arousal (19, 
21, 22). Although these effects are adaptive in response to an acute stressor, persistent or 
inappropriate LC-norepinephrine activation has pathological consequences. Indeed, 
excessive activity of CRF and LC-norepinephrine systems is thought to underlie the core 
feature of hyperarousal in melancholic depression (8, 10, 23). Similarly, CRF hypersecretion 
and increased LC sensitivity have been implicated in post-traumatic stress disorder (24, 25). 
Thus, sex differences in these systems or their interaction could contribute to female 
vulnerability to these stress-related illnesses.
Our previous electrophysiological studies demonstrated sex differences in LC sensitivity to 
CRF and its regulation by prior stress that could be expressed as excessive activation of the 
LC-norepinephrine system in females (26). LC neurons of unstressed female rats were more 
sensitive to CRF compared to males, as indicated by a leftward shift in the CRF dose-
response curve. Additionally, prior swim stress sensitized LC neurons of male rats only to 
low doses of CRF and desensitized them to high doses, such that the CRF dose-response 
curve shifted to the left to match that seen in unstressed females but plateaued at a lower 
level. Together, the findings suggested that the CRF receptor (CRFr), which mediates LC 
activation by CRF, signals and/or is trafficked differently in males and females.
This study was designed to identify the molecular basis for sex differences in neuronal 
sensitivity to CRF. Because CRFr signaling occurs primarily through its coupling to the 
GTP binding protein, Gs, receptor immunoprecipitation was used to determine whether 
CRFr-Gs coupling differed in male and female rats (27). To examine potential sex 
differences in CRFr trafficking, CRFr phosphorylation and association with β-arrestin2 were 
compared, as these are important steps in the CRFr internalization process (28, 29). To 
confirm that the molecular events had cellular consequences, immunoelectron microscopy 
was used to visualize cellular compartmentalization of the receptor and stress-induced 
internalization. The results converged to reveal sexual dimorphism in CRFr function at 
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molecular and cellular levels that could contribute to the higher incidence of certain stress-
related psychiatric disorders in females.
METHODS AND MATERIALS
Subjects
The subjects were male and female Sprague-Dawley rats (Charles River, Wilmington, MA). 
Females were intact or ovariectomized by the vendor at 42 days. Rats were approximately 
47 days of age when shipped and used approximately 2 weeks after arrival. Shipments of 
male and female rats were age matched. See Supplementary Information (SI) Methods for 
details on subjects, housing conditions, and tracking the estrous cycle. Care and use of 
animals was approved by the Children's Hospital of Philadelphia Institutional Animal Care 
and Use Committee and was in accordance with the NIH Guide for the Care and Use of 
Laboratory Animals.
Electrophysiology
Extracellular single unit LC activity was recorded in the halothane-anesthetized state 24 h 
after a 15 min swim stress or brief handling as described (26). The 24 h timepoint was 
chosen to correspond to the time that sex differences in stress regulation of LC sensitivity to 
CRF were observed (26). Surgery and procedures for LC recording coupled with drug 
microinfusion were as previously described with modifications detailed in SI Methods (26). 
Artificial cerebrospinal fluid (ACSF) or the cyclic adenosine monophosphate (cAMP)/
protein kinase A antagonist, Rp-cAMP-S (adenosine-3′, 5′-cyclic monophosphorothioate, 
Rp-isomer, triethylammonium salt), was microinfused into the LC (600 ng in 120 nl ACSF) 
20-40 min before CRF (1-30 ng in 30 nl ACSF). LC activity was recorded at least 6 min 
before and 10 min after CRF. Only one dose of CRF was tested on a single cell and only one 
cell tested in an individual rat. Recording sites were histologically identified as previously 
described (26).
CRFr immunoprecipitation
Tissue was usually collected 24 h after stress or handling, to match electrophysiological 
timepoints. For receptor phosphorylation and β-arrestin2 studies tissue also was collected 
immediately after and one hour after stressor exposure. Unanesthetized rats were placed in a 
flexible plastic restrainer (Decapicone) and rapidly decapitated. Frontal cortex (anterior to 
the +3.20 AP coordinate, relative to Bregma) was dissected and frozen (−80°C). Initial 
studies revealed no sex- or stress-induced differences in cortical CRFr expression indicating 
that cortical samples prepared for the immunoprecipitation procedure contained comparable 
amounts of CRFr protein in each group (see SI Results). CRFr was immunoprecipitated 
from 3 pooled samples for a single determination as detailed in SI Methods.
Western blotting
Immunoprecipitated samples (5 μg per condition) were subjected to SDS-PAGE gel 
electrophoresis and proteins transferred to polyvinylidene fluoride membranes (Immobilon-
FL) as described (26). Membranes were probed for specific proteins as previously described 
with modifications detailed in SI Methods (30). Odyssey Infrared Imaging software 
Bangasser et al. Page 3
Mol Psychiatry. Author manuscript; available in PMC 2011 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
quantified the integrated intensity of each band and determined molecular weights based on 
Biorad Precision Plus Protein Standards. The ratio of target protein (Gs, Go, Gq/11, 
phosphothreonine, or β-arrestin2) to CRFr was calculated and the mean ratios were 
compared between groups using ANOVAs. For the Figures, each individual fluorescent 
channel of the image was adjusted for brightness and contrast using the Odyssey Infrared 
Imaging Software.
Immunoelectron microscopy
Tissue preparation, immunolabeling, and quantification for the immunoelectron microscopy 
studies were as previously described (31, 32). Immunogold-silver and immunoperoxidase 
labeling were used to detect CRFr- and tyrosine hydroxylase (TH)-immunoreactivity, 
respectively. Further details on immunoelectron microscopy methods and quantification are 
in SI (methods and Fig. S3).
Antibody controls
Evidence that the antibodies used are detecting only CRF1 in cortical and LC tissue in these 
studies is described in detail in SI Methods. Thus, CRFr refers to CRF1 in cortical and LC 
tissue in this study.
RESULTS
CRFr signaling is increased in females and differentially regulated by stress compared to 
males
To determine whether sex differences in LC sensitivity to CRF were related to differences in 
cAMP-mediated cellular signaling, initial studies assessed the cAMP-dependent component 
of LC responses to CRF (Fig. 1). LC activation by a relatively low CRF dose (3 ng for males 
and the equieffective dose of 1 ng for females) or a near maximally effective dose of CRF 
for both groups (30 ng) was recorded in the presence of the cAMP and protein kinase A 
antagonist, Rp-cAMP-S, or vehicle. As previously reported (26), in the unstressed state, LC 
neurons of female rats were activated by a dose of CRF that was ineffective in male rats 
(Fig. 1A,B). This response was completely cAMP-dependent because it was abolished by 
Rp-cAMP-S (Fig. 1B). For both sexes, LC activation by the higher dose (30 ng) was 
mediated by both cAMP-dependent and independent processes (Fig. 1A,B). Following swim 
stress, LC neurons of male rats were activated by a CRF dose (3 ng) that was ineffective in 
unstressed male rats, confirming previous findings (26) (Fig. 1C). This sensitized response 
was completely cAMP-dependent, whereas the neuronal response to the higher dose of CRF 
(on the plateau) was cAMP-independent (Fig. 1C). In contrast to what was seen in males, 
the cAMP-dependent profile in females was unchanged by prior stress history (Fig. 1D). 
Finally, there were no significant effects of stress or sex in cAMP-independent signaling.
To determine whether sex differences in neuronal responses to CRF reflected differential 
CRFr-Gs coupling, the amount of Gs pulled down with immunoprecipitated CRFr was 
quantified. The quantity of protein required for receptor immunoprecipitation necessitated 
the use of cortical tissue for these studies. Notably, the CRF1 receptor that is thought to 
mediate LC activation is in high density in the cortex and linked to the cAMP signaling 
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pathway (33-36). Receptor binding and in situ hybridization studies suggest that this is the 
sole CRF receptor subtype in cortex and a lack of staining with a CRF2 receptor antibody 
supported this (33, 37) (See Figs. S2, S3 in SI). Figure 2 shows representative blots of 
immunoprecipitated CRFr and the associated Gs protein pulled down in the different 
experimental groups. In the unstressed condition, the amount of Gs protein 
immunoprecipitated with CRFr was significantly greater for females (either ovariectomized 
or intact) compared to males, indicating greater CRFr-Gs coupling in females (Fig. 2A,D). 
This mirrors the electrophysiological findings of an increased neuronal response of female 
rats to low doses of CRF (26)(Fig.1A,B).
Swim stress increased CRFr-Gs coupling in males to a level comparable to that of unstressed 
females (Fig. 2A,D) and this occurred at the same time that LC neuronal sensitivity to low 
doses of CRF was increased in male rats (26) (Fig. 1C). Swim stress did not significantly 
alter CRFr-Gs coupling in females (Fig. 2A,D). CRFr-Gs association was comparable in 
ovariectomized and intact females in both stressed and unstressed conditions, suggesting no 
contribution of circulating ovarian hormones to this effect. These biochemical results in the 
cortex match the electrophysiological findings in the LC and suggest that enhanced neuronal 
responses to CRF in females and stressed males result from increased CRFr-Gs coupling.
There were no sex or stress-related differences in CRFr association with either Go or Gq/11 
(Fig. 2 B,C,E,F). This is consistent with a lack of sex or stress differences in the non-cAMP 
mediated component of the electrophysiological response to CRF and underscores the 
contribution of CRFr-Gs coupling to sex differences in CRFr function (Fig. 1).
Stress-elicited association of CRFr to β-arrestin2 is not observed in females
The process of receptor internalization regulates cell sensitivity to ligands and agonists of G-
protein coupled receptors (38, 39). CRFr internalization is initiated by phosphorylation of a 
threonine residue on the carboxy terminus and subsequent binding of β-arrestin2 in cultured 
cells and primary cortical neurons (28, 29, 40). Sex differences in CRFr phosphorylation 
were assessed by probing immunoprecipitated CRFr with an antibody directed against 
phosphothreonine. Merging the channels used to visualize phospothreonine- and CRFr-
immunoreactivity revealed an identical band, consistent with detection of the 
phosphorylated receptor (Fig. 3A). There were no sex- or stress-related differences in 
phosphothreonine labeling of CRFr at any timepoint after swim stress (Fig. 3B1-B3).
Detection of β-arrestin2 in immunoprecipitated samples revealed an effect of both sex and 
stress on CRFr-β-arrestin2 association (Fig. 3C, D1-D3). In the unstressed condition, CRFr-
β-arrestin2 association was relatively low and similar in males and females. Stress increased 
CRFr-β-arrestin2 association solely in males at 1 h and 24 h after swim stress, consistent 
with the internalization process (Fig. 3D1-D3) (32). In contrast, stress failed to increase 
CRFr-β-arrestin2 association in females at any timepoint, suggesting that the important 
adaptive process of CRFr internalization may be compromised in females (Fig. 3 D1-D3). 
CRFr-β-arrestin2 association was similar in ovariectomized and intact females in either 
unstressed or stressed conditions.
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Stress-elicited CRFr internalization is not observed in females
Immunoelectron microscopy was used to compare the cellular localization of CRFr between 
groups. Immunogold-silver labeled CRFr was identified in LC dendrites in both male and 
female rats (Fig. 4A-C). CRFr was found within TH-labeled dendrites of female rats as has 
been demonstrated for LC neurons of male rats (32) (Fig. 4C1-C2). Consistent with previous 
reports (32), in unstressed male rats CRFr was more prevalent on the plasma membrane. In 
contrast, in unstressed female rats CRFr was predominantly cytoplasmic (Fig. 4A1, B1, D).
Swim stress induced CRFr internalization in male rats as indicated by a greater ratio of 
cytoplasmic–to-total silver grains 24 h after stress (Fig. 4A2,D). In contrast, a decreased 
ratio of cytoplasmic-to-total silver grains was apparent in females after swim stress, 
suggestive of CRFr recruitment to the plasma membrane (Fig. 4B2, D). Together, the 
immunoelectron microscopy data support the immunoprecipitation and electrophysiological 
studies suggesting that stress causes CRFr internalization in male rats only.
DISCUSSION
The present study provides convergent evidence for sexual dimorphism in CRFr signaling 
and trafficking. Receptor immunoprecipitation revealed greater CRFr-Gs coupling in 
females compared to males in unstressed conditions, consistent with a greater sensitivity to 
CRF determined electrophysiologically. A history of stress increased CRFr-Gs coupling 
only in males to a magnitude comparable to that seen in females, mirroring stress-induced 
changes in neuronal sensitivity to CRF. Sex differences in CRFr-β-arrestin2 association 
corresponded to sex differences in CRFr trafficking determined by electron microscopy. 
These results can account for the earlier plateau in the CRF dose response curve determined 
in male rats in electrophysiological studies (26). Together, the findings identify molecular 
and cellular mechanisms that could result in enhanced sensitivity of females to CRF and a 
decreased ability to adapt to excessive CRF. Because hyperactivity of CRF and LC systems 
are features of certain stress-related disorders that are more prevalent in females (e.g., 
depression, post-traumatic stress disorder), these mechanisms may underlie the well 
recognized vulnerability of females to these conditions.
Sex differences in the CRF system and the role of gonadal hormones
Sexual dimorphism of the CRF system has been demonstrated at multiple levels (for review 
see, (13, 41). Hypothalamic CRF expression is greater in female humans and rodents, and 
certain stressors increase hypothalamic CRF exclusively in females (42-45). Sex differences 
in CRF expression are established by organizational and activational effects of gonadal 
hormones. The perinatal testosterone surge organizes sex differences in adult CRF gene 
expression and mRNA (46, 47). In adulthood, circulating estrogen positively regulates CRF 
and CRF binding protein (CRF-BP) mRNA expression through estrogen response elements 
on their genes (12, 48-50).
The present study provides the first evidence for sexual dimorphism at the level of CRFr. 
Unlike the case for CRF or CRF-BP, circulating gonadal hormones are not involved in sex 
differences in CRFr function, as indicated by molecular findings of the present study or our 
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previous electrophysiological findings (26). Thus, sex differences in CRFr likely result from 
organizational effects of testosterone at critical developmental periods.
Sex differences in CRFr signaling
LC neurons of male and female rats have comparable spontaneous discharge rates and 
responses to sensory stimuli (26). However in the unstressed state, LC neurons of females 
are more sensitive to CRF, as indicated by a shift to the left of the CRF dose-response curve 
for LC activation compared to that determined in male rats (26). This is physiologically 
relevant because it translates to enhanced activation of the LC-norepinephrine system by 
stress (26). Consistent with in vitro studies, a substantial component of LC activation by 
CRF in vivo is mediated by a cAMP-dependent pathway (51). LC activation in unstressed 
females by a CRF dose that was ineffective in males was completely cAMP-dependent. 
Thus, the greater CRFr-Gs coupling in unstressed females revealed by CRFr 
immunoprecipitation studies accounts for the ability of a low CRF dose to activate LC 
neurons by a cAMP-dependent mechanism in females and not males.
Although it would be ideal to use LC tissue for CRFr immunoprecipitation studies, this was 
not feasible given the amount of protein required. Because CRF effects on LC neurons are 
mediated by CRF1, the cortex was an appropriate brain region to use to assess sex 
differences in LC sensitivity to CRF. CRF1 is abundant in cortex and coupled to Gs and 
cAMP formation (52, 53). In contrast to hippocampus and amygdala, CRF1 in cortex is not 
linked to p-ERK1/2 activation (54). The parallel results in these anatomically distinct 
regions suggest that sex differences in CRFr signaling may be a more widespread.
In male rats, previous stress changes the CRF dose-response relationship for LC activation 
in a complex manner: causing a shift to the left in the low dose range and decreasing the 
maximum response. This has been documented for repeated shock, repeated intraperitoneal 
saline injections, and swim stress (55-57). The stress-induced sensitization of male LC 
neurons to low doses of CRF makes the response comparable to that seen in unstressed 
females and, as in females, this response is completely cAMP dependent. Sex and stress 
differences in CRFr-Gs coupling mirrored the electrophysiological differences, supporting 
this as an underlying mechanism for stress-induced neuronal sensitization in males.
Sex differences in CRFr internalization
Internalization of G-protein coupled receptors regulates cell sensitivity to agonists (38, 39). 
Both agonist- and swim stress-induced CRFr internalization in LC neurons of male rats have 
been previously documented (31, 32). As time increases from 1 to 24 h after swim stress, 
CRFr incorporation into multivesicular bodies increases, consistent with receptor 
downregulation (32). The functional consequence of this is an earlier plateau of the CRF 
dose-response curve for LC activation in male rats exposed to swim stress (26). The cellular 
processes involved in CRFr internalization in cultured cells indicate a requirement for 
phosphorylation of a threonine residue Thr399 on the carboxy tail and recruitment of β-
arrestin2 (28). The finding that stress did not alter CRFr-threonine phosphorylation may be 
an indication that stress-induced CRFr internalization in brain requires phosphorylation at 
other sites on the receptor. Alternatively, the technique used in this study may not be 
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sufficiently sensitive to detect differences in phosphorylation sites that are required for 
internalization.
Stress increased CRFr-β-arrestin2 association in males at 1 and 24 h after stress, times at 
which CRFr internalization was apparent in LC neurons (32). The inability of swim stress to 
alter CRFr-β-arrestin2 association in females predicted that the internalization process would 
be impaired and this was confirmed in electron microscopy studies. The finding that CRFr 
was prominent in the cytoplasm in unstressed females and on the plasma membrane in 
stressed females was unexpected. This could reflect stress-induced recruitment of CRFr to 
the plasma membrane. Alternatively, it is possible that unstressed females produce more 
receptors that remain cytoplasmic and this is attenuated by stress, effectively increasing the 
proportion of receptors on the plasma membrane by decreasing the amount in the cytoplasm. 
Evidence for simultaneous receptor internalization and increased coupling in previously 
stressed male rats completely accounts for the complex shift in the CRF dose-response curve 
in male rats with a history of stress (i.e., a shift to the left with a decreased maximum 
response). This suggests that CRFr remaining on plasma membrane after stress is more 
highly coupled.
Relevance of enhanced CRFr signaling in females
Sex differences in CRFr in rat studies should translate to increased sensitivity in rodent 
models of stress-related psychopathology. However, most rodent models of these disorders 
use males exclusively and studies using both sexes are equivocal with regard to whether 
females are more sensitive (for review see, (58-60). An important issue is that many of these 
models (e.g. the forced swim test, open field) use an inhibition of motor activity as an 
endpoint indicative of depressive- or anxiety-like behavior. This is problematic because 
there are baseline sex differences in activity in many rodent species (60). Moreover, it is 
unclear that a decrease in activity appropriately models the hyperarousal that characterizes 
melancholic depression and PTSD, and which is thought to involve LC hyperactivity and/or 
sensitivity.
CRF and stressors shift the mode of LC discharge towards a high tonic-low phasic state that 
is associated with heightened arousal and a shift from a focused to labile attention that 
facilitates scanning the environment (61-63). This is an adaptive behavioral response to 
acute stress. However, if this response is engaged inappropriately or if it persists, this is 
expressed as pathology similar to that described in depression or PTSD (e.g., hyperarousal, 
sleep disturbance, inability to concentrate, anxiogenic behaviors). As a result of increased 
CRFr-Gs coupling, the LC system of females will be activated by stressors (i.e., stimuli that 
release CRF) that are subthreshold for activating the system in males. The lack of CRFr 
internalization in LC neurons of females would be translated to an inability to adapt to high 
levels of CRF as might be produced with chronic stress or in depression, conditions in which 
CRF hypersecretion is hypothesized (64). The vulnerability of females to depression or 
PTSD may in part involve this lower threshold for stress-induced activation of the LC-
norepinephrine system and the potential for a more persistent activation.
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Summary
Complementary approaches identified sex differences in two aspects of CRFr function that 
can contribute to increased CRF sensitivity in females. Increased CRFr signaling and 
compromised internalization would be expressed as increased sensitivity to low levels of 
CRF and compromised adaptation to high levels of CRF in females. This enhanced 
postsynaptic CRF function may be an important molecular mechanism underlying the 
vulnerability of women to stress-related psychiatric disorders. Finally, these findings 
underscore the importance of considering sexual dimorphism in CRFr function in 
developing CRFr antagonists for the treatment of psychiatric disorders that are more 
prevalent in females.
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Figure 1. 
The role of cAMP signaling in the sex- and stress-related differences in LC neuronal 
activation by CRF. (A-D) LC activation by local CRF after pretreatment with Rp-cAMP-S 
(600 ng in 120 nl, intra-LC) or ACSF (120 nl) is shown for unstressed male (n=5-8) and 
female rats (n=4-6) and male (n=6-8) and female rats 24 h after swim stress (n=4-6). Bars 
depict the average response to CRF following ACSF (black) or Rp-cAMP-S (dark gray). 
Light gray bars represent the cAMP-mediated component (calculated by taking the 
difference between the vehicle and Rp-cAMP-S treated groups). In the unstressed state, a 
relatively low CRF dose activated LC neurons in females only [t(6)=3.56, p<0.05], and this 
response was completely cAMP-dependent. For both males and females, neuronal responses 
to the higher dose (30 ng) were mediated by cAMP-dependent and independent processes 
[F(1,26)=12.88, p<0.05] . Swim stress changed the cAMP signaling profile in males 
{stress×dose×drug interaction [F(1,46)=4.45, p<0.05]}, but not in females [F(1,39)=1.87, 
p>0.05].
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Figure 2. 
Sex- and stress-related differences in CRFr association with different G proteins. (A-C) 
Representative blots of immunoprecipitated CRFr (green, MW=52kD) from different groups 
and (A) the Gs protein (red, MW=48kDa), (B) the Go protein (red, MW=40kDa) and (C) the 
Gq/11 protein (red, MW=40kDa). So that the presentation in A, matched that in B and C, a 
lane containing the molecular weight marker that was between female and male samples on 
the same gel was deleted and the image of male samples that were to the right of this lane 
were moved to the left of female samples. (D-F) Graphs show the mean ratio of the 
integrated intensity of each band of G proteins to the corresponding band of CRFr from the 
same samples (n=4-6 determinations, pooled 3 rats per determination). CRFr-Gs coupling 
was greater in unstressed ovariectomized and intact females compared to unstressed males 
[F(5,26)=2.56, p<0.05, post-hocs p<0.05]. Stress increased coupling in males (p<0.05) to a 
level comparable to that of unstressed females (p>0.05), but had no further effect on females 
(regardless of hormonal status; p>0.05). There were no significant differences in coupling of 
the CRFr to Go [F(3,20)=0.55, p>0.05] or Gq/11 [F(3,12)=0.55, p>0.05] (top band 
quantified). Data are represented as the mean (±SEM). Number sign indicates sex difference 
under basal (unstressed) conditions (i.e., greater coupling in unstressed females vs. 
unstressed males; p<0.05). Asterisks indicate a significant stress-induced increase compared 
to the unstressed same sex control (p<0.05).
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Figure 3. 
Sex differences in proteins involved in CRFr internalization processes. (A) Blots represent 
the phosphothreonine band (red), CRFr band (green) and the merged image (yellow) 
indicating that both label the same protein (i.e., phosphorylated CRFr , MW=52 kDa). 
Protein for this blot was collected 24 h after stressor exposure. (B1-3) Bar graphs show the 
mean ratio of phosphothreonine:CRFr for each condition from tissue collected immediately 
[F(3,12)=0.39, p>0.05], 1 h [F(3,20)=0.58, p>0.05]or 24 h [F(3,20)=0.66, p>0.05] post-
stress (n=4-6 determinations, pooled 3 rats per determination). (C) The Western blot shows 
the β-arrestin2 band (MW = 54 kDa) and the CRFr band 24 h after stressor exposure or 
handling. (D1-3) Graphs illustrate the ratio of β–arrestin2:CRFr for rats sacrificed 
immediately [F(3,12)=0.52, p>0.05], 1 h [F(3,16)=4.74, p<0.05] or 24 h post-stress 
[F(5,30)=5.77, p<0.05] (n=4-6 determinations, pooled 3 rats per determination). At both 1 
and 24 h after stress, β–arrestin2 association with the CRFr was significantly increased in 
males (p<0.05) but not in females (p>0.05). Cycling females were included for an additional 
comparison at the 24 h timepoint, and there was no statistically significant difference in 
CRFr-β-arrestin2 association between ovariectomized and cycling females in either the 
unstressed or stressed condition (p>0.05). Data are represented as the mean (±SEM). 
Asterisks indicate a significant effect of stress compared to unstressed same sex control 
(p<0.05).
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Figure 4. 
Electron microscopic visualization of CRFr compartmentalization and stress-induced 
trafficking in LC dendrites. A-C are electron photomicrographs of sections through the LC. 
(A1) LC dendritic profile (d) in an unstressed male rat with immunogold-silver labeling for 
the CRFr along the plasma membrane (arrowheads). The dendrite receives synaptic contacts 
from axon terminals (t). (A2) Dendrite from a male rat 24 h following swim stress. CRFr 
labeling shifts from the plasma membrane to the cytoplasm. (B1) Dendrite from an 
unstressed female rat shows that CRFr is prominent in the cytoplasm. (B2) Dendrite from a 
female rat 24 h following swim stress shows that CRFr labeling shifts from the cytoplasm to 
the plasma membrane. (C1-2) TH-immunoperoxidase-labeled dendrites containing 
immunogold-silver labeling for CRFr (CRFr+TH) in a female control (C1) and a stressed rat 
(C2). Arrowheads point to CRFr on the plasma membrane in C2. Arrows point to 
immunoperoxidase reaction product. (D) Bar graph indicating the percentage of internalized 
receptors for each condition (n=3, mean per rat generated from at least 125 dendritic 
profiles). Unstressed females had a significantly greater percentage of cytoplasmic receptors 
than unstressed males [F(1,8)=45.3, p<0.05, post-hoc, p<0.05]. Swim stress increased the 
percentage of CRFr in cytoplasm in males rats (p<0.05). In contrast, swim stress decreased 
the percentage of cytoplasmic CRFr in females (p<0.05). Data are represented as the mean 
(± SEM). Number sign indicates sex difference under unstressed conditions (p<0.05). 
Asterisks indicate a significant effect of stress compared to the unstressed same sex control 
(p<0.05). Scale bars=500 nm (A-C).
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